1. Home
  2. LABT vs WNW Comparison

LABT vs WNW Comparison

Compare LABT & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lakewood-Amedex Biotherapeutics Inc. Common Stock

LABT

Lakewood-Amedex Biotherapeutics Inc. Common Stock

N/A

Current Price

$2.05

Market Cap

4.6M

Sector

Health Care

ML Signal

N/A

Logo Meiwu Technology Company Limited

WNW

Meiwu Technology Company Limited

HOLD

Current Price

$2.41

Market Cap

4.5M

ML Signal

HOLD

Company Overview

Basic Information
Metric
LABT
WNW
Founded
N/A
2015
Country
United States
China
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Catalog/Specialty Distribution
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
4.6M
4.5M
IPO Year
N/A
2019

Fundamental Metrics

Financial Performance
Metric
LABT
WNW
Price
$2.05
$2.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
72.4K
Earning Date
N/A
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$1.14
Revenue Growth
N/A
N/A
52 Week Low
$1.66
$0.05
52 Week High
$6.85
$13.52

Technical Indicators

Market Signals
Indicator
LABT
WNW
Relative Strength Index (RSI) 39.79 37.77
Support Level $1.85 $1.28
Resistance Level $2.92 $4.36
Average True Range (ATR) 0.64 0.26
MACD -0.01 -0.06
Stochastic Oscillator 7.51 10.77

Price Performance

Historical Comparison
LABT
WNW

About LABT Lakewood-Amedex Biotherapeutics Inc. Common Stock

Lakewood-Amedex Biotherapeutics Inc is a clinical-stage biotechnology company developing a novel class of fast-acting, broad-spectrum antimicrobials - the Bisphosphocin class - to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. The company's main product is Nu-3, a topically delivered antimicrobial gel in Phase 2 clinical trials for the treatment of mildly infected diabetic foot ulcers (iDFU). It is also advancing a portfolio of early-stage pipeline compounds developed from its Bisphosphocin platform targeting potential disease indications, including complicated urinary tract infection (cUTI) and pulmonary infections.

About WNW Meiwu Technology Company Limited

Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.

Share on Social Networks: